Next Article in Journal
Crossbred Sows Fed a Western Diet during Pre-Gestation, Gestation, Lactation, and Post-Lactation Periods Develop Signs of Lean Metabolic Syndrome That Are Partially Attenuated by Spirulina Supplementation
Next Article in Special Issue
Supplementation with Queen Bee Larva Powder Extended the Longevity of Caenorhabditis elegans
Previous Article in Journal
Contribution of Advanced Glycation End Products to PCOS Key Elements: A Narrative Review
Previous Article in Special Issue
Systems Biology Approaches for Understanding Metabolic Differences Using ‘Multi-Omics’ Profiling of Metabolites in Mice Fed with Honey and Mixed Sugars
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

General Nutritional Profile of Bee Products and Their Potential Antiviral Properties against Mammalian Viruses

by
Syeda Tasmia Asma
1,
Otilia Bobiş
2,*,
Victoriţa Bonta
2,
Ulas Acaroz
1,*,
Syed Rizwan Ali Shah
3,
Fatih Ramazan Istanbullugil
4 and
Damla Arslan-Acaroz
5
1
Department of Food Hygiene and Technology, Faculty of Veterinary Medicine, Afyon Kocatepe University, Afyonkarahisar 03200, Turkey
2
Department of Beekeeping and Sericulture, University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca, 400372 Cluj-Napoca, Romania
3
Department of Animal Nutrition and Nutritional Diseases, Faculty of Veterinary Medicine, Afyon Kocatepe University, Afyonkarahisar 03200, Turkey
4
Department of Food Hygiene and Technology, Faculty of Veterinary Medicine, Kyrgyz-Turkish Manas University, Bishkek KG-720038, Kyrgyzstan
5
Department of Biochemistry, Faculty of Veterinary Medicine, Afyon Kocatepe University, Afyonkarahisar 03200, Turkey
*
Authors to whom correspondence should be addressed.
Nutrients 2022, 14(17), 3579; https://doi.org/10.3390/nu14173579
Submission received: 19 July 2022 / Revised: 24 August 2022 / Accepted: 26 August 2022 / Published: 30 August 2022
(This article belongs to the Special Issue Bee Products in Human Health)

Abstract

:
Bee products have been extensively employed in traditional therapeutic practices to treat several diseases and microbial infections. Numerous bioactive components of bee products have exhibited several antibacterial, antifungal, antiviral, anticancer, antiprotozoal, hepatoprotective, and immunomodulatory properties. Apitherapy is a form of alternative medicine that uses the bioactive properties of bee products to prevent and/or treat different diseases. This review aims to provide an elaborated vision of the antiviral activities of bee products with recent advances in research. Since ancient times, bee products have been well known for their several medicinal properties. The antiviral and immunomodulatory effects of bee products and their bioactive components are emerging as a promising alternative therapy against several viral infections. Numerous studies have been performed, but many clinical trials should be conducted to evaluate the potential of apitherapy against pathogenic viruses. In that direction, here, we review and highlight the potential roles of bee products as apitherapeutics in combating numerous viral infections. Available studies validate the effectiveness of bee products in virus inhibition. With such significant antiviral potential, bee products and their bioactive components/extracts can be effectively employed as an alternative strategy to improve human health from individual to communal levels as well.

1. Introduction

Bee products offer propitious health benefits and are more and more popular in the era of medicinal research. They have also been well known for their nutritional benefits and therapeutic activity since approximately 5500 years ago [1]. In ancient times, people collected honeybees individually by hand, which is still in practice [2]. Several bee products (honey, propolis, bee pollen, bee bread, royal jelly, bee venom, and bee wax) have been recognized over time as potential sources of bioactive substances with medicinal potential in the treatment of several infections caused by viruses, bacteria, and parasites [3,4]. Moreover, viruses play an important role as causative agents in different cancer types, which are deadly diseases and the leading cause of worldwide deaths [5,6,7]. It was reported that viruses induce about 1.4 million cancers per year, which is roughly 10% of worldwide cancer cases [8]. Several studies have reported that commonly used bee products such as honey, propolis, royal jelly, bee pollen, and bee venom have significant potential for the treatment of different types of cancers [3,9].
Honey is an oxidizing agent with anti-inflammatory, antiproliferative, immunomodulatory, proapoptotic, antimetastatic, and antimicrobial properties [10,11,12]. Bee venom acts as apitoxin or biotoxin prepared by bee glands and secreted in the abdominal cavity of bees. It was also found to be effective in the treatment of different types of cancers, with effects such as cancer cell proliferation inhibition, induction of apoptosis, cytotoxicity, and necrosis [13]. Propolis, commonly known as bee glue, is made up of pollen, essential oils, waxes, resins, and various organic substances, including minerals, amino acids, flavonoids, polyphenols, ethanol, and different vitamins. It actively acts against hive-invading pathogenic microorganisms, including viruses and bacteria [14,15]. Finally, bee products are well known for their antiviral properties (Figure 1), which can surpass the standard available drugs in different cases. Indeed, propolis and honey have been observed to induce significant antiviral activities against different pathogenic mammalian viruses, including herpesviruses [16], influenza viruses [17], HIV, respiratory syncytial virus (RSV) [18], human T-cell leukemia virus type 1 (HLTV-1) [19], dengue virus (DENV) [20], Newcastle disease virus (NDV) [21], and poliovirus (PV). In addition, bee pollen and bee bread were efficacious antivirals against herpes virus types 1 and 2 (HSV-1 and HSV-2) in an in vitro study [22]. They were also reasonably effective against three influenza virus strains (H1N1, H3N2, and H5N1) [23]. Several clinical studies have suggested their practical use in place of antiviral drugs. Propolis can also be used to effectively inhibit HSV-1 and HSV-2 replication. A significant quantitative reduction in the viral copies of HSV-1 and HSV-2 confirmed the antiviral activity of propolis [24]. Vynograd et al. (2000) [25] investigated the efficacy of Canadian propolis ointment compared with acyclovir and placebo ointments in managing the herpes simplex virus. The healing capacity and the antimicrobial activity against the vaginal microflora were significantly enhanced by Canadian propolis as compared to acyclovir or placebo. Its antiviral activity was synergistically enhanced in combination with acyclovir [26]. Recently, bee products, more specifically propolis and honey, have been effectively clinically tested against SARS-CoV-2 due to their potential antiviral properties [27].
In addition to numerous antibacterial, antiviral, and anticancer activities, bee products have also generated significant antiprotozoal action against Giardia lamblia and Caenorhabditis [28,29,30]. Propolis was found to exert antimalarial effects against Plasmodium species, including P. falciparum, P. ovale, P. vivax, and P. malariae [31]. Several studies reported that royal jelly yielded antimicrobial activity against numerous pathogenic microorganisms [27]. Beeswax is another kind of bee product found to induce significant antimicrobial activity against pathogenic microbes [32]. Bee pollen has been reported to induce bactericidal and bacteriostatic activities [33]. The current review discusses the general composition and potential antiviral activities of bee products as a beneficial resource material for researchers to study the currently available studies and to discover more antiviral possibilities of bee products against mammalian viruses.

2. Honey

Honey produced by honeybees is a natural product extensively used as a food and medicinal source [34]. It is a complete food with several medicinal properties and has been used to treat gastrointestinal diseases, burns, wounds, inflammation, different ulcers, and abscesses and as a contraceptive [35].

2.1. Composition of Honey

Honey’s general composition is represented by different simple sugars and water. Its minor components, such as proteins and amino acids, enzymes, organic acids, flavonoids, volatile compounds, vitamins, and minerals, differentiate honeys originating from different botanical sources. Honey characteristics such as aroma, color, and flavor directly depend upon factors such as the honeybee species, floral source, climatic conditions, processing methods, packaging, and storage conditions [36]. Sugars are known as the major constituents of honey, ranging from 70–80%, containing about 70% monosaccharides (glucose and fructose) and about 10% di- and trisaccharides (maltose, sucrose, trehalose, turanose, isomaltose, kojibiose, maltulose, nigerose, maltotriose, erlose, and melezitose) [37,38]. In addition, proteins are also minor constituents of honey, including different enzymes and free amino acids. Among amino acids, proline is found in the highest amounts in honey. Furthermore, histidine, aspartic acid, glycine, glutamic acid, glutamine, threonine, tyrosine, alanine, a-alanine, b-alanine, aminobutyric acid, tryptophan, threonine, valine, arginine, methionine, lysine, serine, cysteine, asparagine, leucine, isoleucine, ornithine, and phenylalanine are also present in honey [39].
Honey contains different water-soluble vitamins, such as complex B (B1, B2, B3, B5, B6, B8, B9, and H) and vitamin C. Vitamin C is partly responsible for the antioxidant effect of honey [40]. Organic acids found in honey range from around 0.57% of the total weight and can induce electric conductivity and minor acidity, influencing the taste and color of honey. Organic acids are developed as a result of nectar conversion into honey following physical and chemical modifications. Some commonly found organic acids are citric acid, glutamic acid, aspartic acid, lactic acid, fumaric acid, butyric acid, malonic acid, acetic acid, gluconic acid, quinic acid, tartaric acid, formic acid, galacturonic acid, glyoxylic acid, malic acid, glutaric acid, propionic acid, α-hydroxyglutaric acid, lactic acid, 2-hydroxybutyric acid, pyruvic acid, oxalic acid, isocitric acid, succinic acid, α-ketoglutaric acid, 2-oxopentanoic acid, methylmalonic acid, shikimic acid, and gluconic acid, which is the most vital type of organic acid in the composition of honey [41]. More than 400 different volatile components, including benzene derivatives, C13-norisoprenoids, sesquiterpenes, monoterpenes, terpenes, fatty acids, alcohols, ketones, aldehydes, and esters, have been observed in honey. These compounds are responsible for their taste and may differ depending upon the nectar origin and processing and storage conditions [42,43]. The general composition of honey is given in Figure 2.
The phenolic components of honey are divided into flavonoids (anthocyanidin, chalcones, flavanols, flavones, flavanones, and isoflavones) and non-flavonoids (phenolic acids) (Figure 3) [44]. Non-flavonoids are present in two primary forms: hydroxycinnamic and hydroxybenzoic acids. Several flavonoids have been identified in honey, such as quercetin, myricetin, kaempferol, chrysin, pinocembrin, pinobanksin, galangin, hesperetin, caffeic acid, ellagic acid, syringic acid, ferulic acid, vanillic acid, p-coumaric acid, gallic acid, rosmarinic acid, benzoic acid, and chlorogenic acid. Some minor elements, including silver, arsenic, barium, calcium, cadmium, cobalt, chromium, copper, iron, potassium, iodine, magnesium, manganese, sodium, nickel, phosphorus, lithium, selenium, and zinc, are also found in honey [45]. The mineral content of honey ranges between 0.04% in light types and 0.2% in dark types of honey, respectively. Few heavy metals, in from 0.2–0.04% in dark and light kinds of honey, respectively. A few heavy metals, including arsenic, cadmium, mercury, and lead, are also observed in honey but should not surpass the maximum residual limit [46].
All of these components are of important nutritional value, with honey being a food product with valuable nutritional properties.

2.2. Antiviral Activity of Honey

Viral infections are considered the most prevalent and deadly infections among all other microbial infections because many viruses remain infectious for a long period in dry mucous [47]. As viruses replicate in the host cells, their destruction also means the destruction of host cells, and vaccination is the best method to prevent viral infections [48]. Several investigations have determined the therapeutic impact of honey and its bioactive compounds against many viral infections. They may protect against the respiratory syncytial virus, varicella-zoster virus (VZV), influenza, herpes simplex viruses, immunodeficiency virus, rubella virus, AIDS, rhinoconjunctivitis, gingivostomatitis, viral hepatitis, rabies, and SARS-CoV-2 (Table 1) [49,50,51,52,53,54,55,56,57,58,59]. The exact mechanism of action of honey and its bioactive compounds is immense and still unknown. Bioactive components such as quercetin, chrysin, kaempferol, etc., may provide antiviral activity by preventing the entry, entrapment, and replication of viruses (Figure 4).
Honey can be considered a significant strategy to treat VZV infection, as it can be easily applied to the skin. A study showed the safe and effective topical application of honey for the treatment of genital and herpes lesions [60,61]. An investigation of the antiviral activity of honey (clover and manuka honey) exhibited significant activity against VZV [62]. The antiviral properties of honey and its particular bioactive components have been analyzed against the respiratory syncytial virus (RSV). The obtained results indicated that treatment with honey encouraged viral replication inhibition. It has also been observed that sugar components are involved in virus inhibition, and simultaneously, it has also been found that methylglyoxal may enhance the antiviral potential of honey against RSV [18]. Based on the obtained results, it can be concluded that honey can be used as an alternative therapy for treating RSV. Influenza is highly contagious and more threatening than RSV in all age groups [63]. Influenza viruses mainly spread via inhalation transmission through sneezing or coughing droplets. Several studies have investigated the anti-influenza activity of honey [17]. Moreover, the significant synergistic effect of honey in combination with propolis has also been examined against the influenza virus [64].

2.3. Adverse Effects of Honey

Several toxic components have been identified in honey, such as diterpene grayanotoxins in honey from Rhododendron ponticum and Rhododendron luteum plants species of the rhododendron [65]. This type of honey is known as “mad honey”; it may cause serious neural intoxication, particularly in Turkey’s Black Sea area. Despite the mad honey’s toxicity, it is employed in folk medicine, especially for sexual dysfunction, hypertension, and some other illnesses [66,67].
Fabaceae, Boraginaceae, and Asteraceae plants generate pyrrolizidine alkaloid substances that are not toxic but can be transformed into harmful substances (pyrrolic metabolites) via the liver after the ingestion of honey [68]. Intoxication cases (characterized by memory loss, delirium, and seizures) have been reported in New Zealand, caused by consuming honey contaminated with neurotoxic sesquiterpene lactones hyenanchin and tutin [69,70,71]. Some other secondary metabolites of plants have been found in honey that are known to have harmful influences on humans, such as oleandrigenin and oleandrin (Apocynaceae), gelsemine and strychnine (Gelsemiaceae), saponins (Sapindaceae), hyoscine, and hyoscyamine (Solanaceae) [69,70,71,72].

3. Bee Pollen

Bee pollen is a mixture of flower pollen, nectar, and bee secretions, which honeybees transform into bee bread inside the hive, providing a nutritional source for colony formation and maintenance [73]. The insects gather flower pollen grains and mix them with nectar and/or honey and salivary secretions to amalgamate them, developing pollen loads. These formed grains are carried on their legs into the hive for storage, fermentation, and further consumption [74]. About 250 components have been identified in bee pollen [75]. Among these constituents, proteins, fatty acids, vitamins, and minerals (Figure 5) have been found to exert antibacterial, antioxidant, antifungal, antiallergic, anti-inflammatory, antitumor, and hepatoprotective activities [76]. The nutritive value of bee pollen is attributable to sugars, proteins, and lipids, which are found in balanced proportions in its composition [77,78].

3.1. Composition of Bee Pollen

The composition of bee pollen (Figure 5) varies greatly depending on the geographical and botanical source of the flower pollen grains, the main source of the developed pollen loads. Its main constituents include 5–60% proteins, 13–55% sugars, 0.3–20 crude fiber, and 4–7% lipids, amino acids, and nucleic acids [78]. The protein content in bee pollen may vary depending upon its botanical source, as presented in Table 2 [79,80,81,82,83,84,85,86,87].
Mineral components, including Ca, Cu, Fe, K, Mg, and Na, have been found in bee pollen. Several enzymes and vitamins, such as vitamin E (tocopherol), thiamine, folic acid, provitamin A (β-carotene), biotin, and niacin, have also been identified [88]. The fatty acid components include archaic, γ-linoleic, and linoleic acids, phytosterols, terpenes, and phospholipids [89]. Frequently found flavonoids are quercetin, catechins, isorhamnetin, and kaempferol [90]. Lutein was found to be the major carotenoid in Callendula officinalis, Taraxacum officinale, and Anthylis sp. bee pollen from Romania [91], as well as small amounts of β-criptoxanthin and β-carotene.

3.2. Antiviral Activity of Bee Pollen

Bee pollen has been documented as a significant nutritional supplement with several therapeutic actions, such as antibacterial, antifungal, antiallergic, antioxidant, anticancer, immunomodulatory, and hepatoprotective activities [76]. Only one study on its antiviral activity was found. Lee et al. (2016) investigated the anti-influenza activity by isolating a few bioactive components (one alkaloid and six flavonoids) of bee pollen. All of the bioactive components showed significant anti-influenza activity. The most effective results were observed with luteolin [23].

3.3. Adverse Effects of Bee Pollen

Bee pollen derived from different sources, such as Echium vulgare, Senecio jacobaea, and Symphytum officinale, may have hepatotoxic properties due to the presence of pyrrolizidine alkaloids at toxic levels [92]. Health issues associated with bee pollen consumption may arise from several other contaminants, such as bacteria, pesticides, heavy metals, and mycotoxins [93,94].

4. Bee Bread

Bee bread is formed by anaerobic fermentation by different Lactobacillus spp. of bee pollen in the hive. It contains different proteins, lipids, carbohydrates, fatty acids, free amino acids, water, vitamins, and some bioactive compounds [95]. It is used as a meaningful food supplement due to its high nutritional content. Its significance as a nutraceutical or food supplement is largely based on its composition [96].

4.1. Composition of Bee Bread

Bee bread (Figure 5) is prepared by worker bees using pollen collected from plants [97]. It is composed of proteins, lipids, carbohydrates, fatty acids, free amino acids, vitamins, minerals, water, and some bioactive components [98]. The protein content ranges from 14.1–37.3 g/100 g, with a mean value of about 23.1 g/100 g, quite similar to that of bee pollen (23.8 g/100 g). Some commonly found enzymes in bee bread are glucose-oxidase, phosphatase, and amylase. Bee bread contains several amino acids, including proline, glutamic acid, valine, aspartic acid, arginine, isoleucine, histidine, lysine, leucine, phenylalanine, methionine, tyrosine, tryptophan, alanine, serine, cysteine, and glycine.
The lipid content in bee bread composition varies depending upon the pollen-producing plant origin. Icosa-tetraenoic and octadecenoic acids, accounting for about 15%, are abundantly found unsaturated fatty acids [99]. The carbohydrate content of bee bread ranges from 24.40 to 34.80%. Fructose is present in the highest quantity, around 57.51%, followed by glucose, maltose, and sucrose at 42.59%, 3.34%, and 0.12% of the fresh weight, respectively. Minerals found in bee bread include Ca, P, Na, Mg, Mn, Fe, Cu, K, S, and Al. K is the mineral with the largest concentration content in bee bread, about 0.74%, followed by 0.65% P and Ca [89]. Nutritional value is very important in bee bread, as reported by several studies, due to the equilibrated composition of sugars, proteins, and lipids and also the presence of unsaturated fatty acids and essential amino acids [77,79,80,82,86,91,98].

4.2. Antiviral Activity of Bee Bread

A few investigations have evaluated the microbicidal activity of bee bread against several bacterial and fungal pathogens [100,101]. However, as far as we know, the antiviral activity of bee bread has not been evaluated so far. Only one study was found on the antiviral activity of bee bread by Didaras et al. [102], who investigated the antiviral effect of bee bread and bee pollen against Enterovirus-D68. Bee bread and bee pollen showed a significant virucidal impact, obtained with IC50 values ranging from 0.048 and 5.45 mg/mL, respectively. This study suggested that bee bread and bee pollen are auspicious antiviral agents and should be further investigated against various viruses to scrutinize their antiviral potentiality.

5. Propolis

Propolis is a resinous bee product produced by different plants and collected by Apis mellifera bees with a waxy texture. Bees use their mandibles for the collection of plant resins to produce propolis. Chemically, it can be described as a complex mixture constituting several bioactive compounds with antifungal, antibacterial, antiparasitic, antiviral, immunomodulatory, and hepatoprotective actions [103].

5.1. Composition of Propolis

The composition of propolis (Figure 6) varies depending upon the floral source, collection time, and genetic background of bees [104]. Its content typically includes plant resins and balsams (55%), waxes (30%), aromatic and essential oils (10%), pollens (5%), and some other substances (5%) [105]. Moreover, more than 500 molecules have been recognized in propolis composition, including phenolics, wax, terpenes, sugars, proteins, vitamins, and amino acids [106]. The phenolic components comprise high amounts and different types of chemical constituents, including phenolic acids, flavonoids, aldehydes, coumarins, esters, simple phenols, and lignans. Flavonoids are distinct components of propolis, such as galangin, pinocembrin, chrysin, and pinobanksin. So far, more than 150 flavonoids have been identified and studied in propolis [105].
Flavanones, another substantial group of flavonoids, have also been identified in propolis. Forty different types of flavanones have been identified in propolis. Pinostrobin, liquiritigenin, pinocembrin, naringenin, isosakuranetin, and sakuranetin are the most commonly reported flavanones [107]. In addition to flavanones, some flavonols, and flavones such as quercetin, chrysin, acacetin, pectolinarigenin, tectochrysin, kaempferol, apigenin, galangin, fisetin, and izalpinin have also been identified [108].
Two major types of phenolic acids present in propolis are hydroxycinnamic acids (caffeic, ferulic, and p-coumaric acids) and hydroxybenzoic acids (salicylic gallic, protocatechuic, vanillic, and gentisic acids). The biological activities (pharmacological effects on living organisms) of propolis are directly dependent upon its composition (chemical). In ancient times, the Egyptians, Romans, and Greeks used propolis as a disinfectant and wound-healing substance. It has been reported as a safe (non-toxic) product for human use [109].

5.2. Antiviral Activity of Propolis

During the last few decades, several researchers have investigated the antiviral activities of propolis against various RNA and DNA viruses, such as HSV-1 and -2, PV-2, VSV, adenovirus-2, and an acyclovir-resistant mutant. Several studies have reported on the antiviral properties of different types of propolis and its bioactive components against various viruses, such as NDV, adenovirus, VSV, HSV, PV, influenza viruses, Vaccinia virus, VZV, IBDV, rotavirus, and coronavirus, as presented in Table 3 [26,110,111,112,113,114,115,116]. The antiviral activity of flavonols was observed to be more significant as compared to flavones present in propolis. The antiviral activity of flavone in combination with flavonol was also explored against HSV-1. The obtained results indicated a considerable synergistic effect that significantly increased the antiviral potential of propolis [117]. The inhibition of PV proliferation was examined by virus multistep replication and a plaque reduction assay. HSV titer was reduced to 1000 by propolis at a 30 µg/mL concentration, while adenovirus and VSV were observed to be less prone. The antiviral activity of propolis and, more specifically, its bioactive components, such as chrysin, quercetin, galangin, luteolin, kaempferol, and apigenin, were examined against HSV [118].
The antiviral potential of ethanol and aqueous propolis extracts and its components, such as chrysin, pinocembrin, galangin, and caffeic, benzoic, and p-coumaric acids, were analyzed against HSV-1, resulting in a more than 98% reduction in plaque formation [111]. The antiviral activity of caffeic acid was observed to be more or less sensitive, in that adeno and vaccinia viruses are more susceptible as compared to parainfluenza and poliovirus and less susceptible to influenza virus [119]. Ethanol and aqueous propolis extracts were investigated against HSV-1 and -2. These propolis extracts showed a 49% viral reduction against HSV-2 infectivity [120]. Thirteen different ethanol extracts were prepared using Brazilian green propolis and tested against the influenza virus. All 13 extracts showed significant in vivo and in vitro anti-influenza activity [53].
Propolis exhibited virucidal effects against enveloped viruses such as VSV and HSV. Propolis samples from four countries, namely, Germany, Egypt, Austria, and France, were studied against infectious bursal disease virus and avian reovirus (ARV). The obtained results revealed that all samples of propolis significantly decreased the infectivity of viruses [121]. Egyptian propolis exhibited the highest antiviral efficacy against IBDV and ARV [122]. Hydromethanolic geopropolis (HMG) extract was analyzed against the herpes virus via electron microscopy and viral DNA quantification and displayed 98% viral reduction [123]. The antiviral potential of Hatay (Turkish) propolis was evaluated against HSV-1 and -2. All concentrations (25, 50, and 100 µg/mL) of propolis showed significant antiviral potential against herpes viruses as compared to acyclovir. Moreover, a solid synergistic antiviral potential was observed when acyclovir was used in combination with propolis as compared to alone [124].

5.3. Adverse Effects of Propolis

Toxic effects of propolis have been observed at high doses, such as 15 g/day [125]. Despite the significant nutritional profile of propolis, it may induce allergic reactions. It has also been found that dermatitis patients are sensitive to propolis [126].

6. Bee Venom

Bee venom is a transparent and inodorous liquid amalgam of proteins (with 4.5–5.5 pH), mostly used by bees to protect themselves against different predators. In liquid form, one drop of it contains only 0.1 µg of venom (dried weight) and about 88% water. It is a complex mixture of different peptides, enzymes, minerals, and amino acids [127].

6.1. Composition of Bee Venom

Bee venom is prepared by female worker bees and constitutes several active compounds, including peptides such as apamin, melittin, adolapin, and mast cell degranulating peptide (MCD); enzymes such as hyaluronidase and phospholipase A2 (PLA2); minerals (Ca, Mg, and P); bioactive amines such as histamine, dopamine, and noradrenaline; and some volatile compounds containing complex ethers (Table 4) [128,129]. Melittin is known as its vital component, ranging from 40–60% of the entire composition [130]. Apamin, containing 2-disulfide bridges, is a polypeptide of 18 amino acids and is the smallest neurotoxin present in bee venom. Apamin can cross the blood–brain barrier (BBB) and hence can influence the functioning of the central nervous system [131]. MCD is very similar to the apamin peptide structure, as it also contains 2-disulfide bonds but with 22 amino acids. It is recorded at about 2–3% of the total dry weight of bee venom. Adolapin is about 0.5–1% of the total dry weight of bee venom and contains 103 amino acids. Phospholipase A2 is a polypeptide with four disulfide bridges containing 128 amino acids, also known as the lethal enzyme of bee venom. Hyaluronidase is another enzyme in bee venom composition with 1.5–2% dry weight and can break down hyaluronic acid present in tissues, such as in synovial bursa in patients with rheumatoid arthritis [132].
Various studies have reported the positive impacts of bee venom, providing antimicrobial, antiviral, anticancer, anti-inflammatory, antimalarial, and hemolytic effects based on the bioactive compounds of bee venom. The therapeutic efficacy of its bioactive compounds has been tested in the treatment of central nervous system diseases (Alzheimer’s disease and Parkinson’s disease), human inflammatory diseases, prostate and ovarian cancers, amyotrophic lateral sclerosis (ALS), HIV, and several other conditions [133,134,135].

6.2. Antiviral Activity of Bee Venom

Bee venom and its components have exhibited significant antiviral activities against several viruses (Table 5) [136,137,138,139], including herpes simplex virus, respiratory syncytial virus, vesicular stomatitis virus, influenza virus, enterovirus-71, influenza A virus, coxsackievirus, and papillomaviruses (HPVs). Papillomaviruses are known as the most common cause of cervical carcinoma induction. Bee venom can significantly inhibit cancer cell growth by downregulating E6/E7 proteins [136,140].
Melittin, a bee venom peptide, can activate the immune system against porcine reproductive and respiratory syndrome viruses (PRRSV) by upregulating Th1 cytokines (IL-12 and IFN-) and other immune cells, such as gd-T cells, CD3+–CD8+, and CD4+–CD8+, causing a decrease in viral load and a reduction in infection severity (in pigs infected with PRRSV) [137]. Phospholipase A2 and its constituent P3bv peptide exhibited considerable activity against human immunodeficiency virus (HIV) by preventing cellular fusion and inhibiting the virus’s (T-tropic) replication. Comparatively, PLA2 can inhibit T- and M-tropic viruses but cannot prevent cellular fusion. It has also been demonstrated that the peptides PLA2 and P3bv have both shown different inhibition mechanisms against HIV replication. P3bv is probably associated with a chemokine receptor, CXCR4, and simultaneously, PLA2 is associated with a binding receptor with high affinity [141]. Secreted phospholipase A2 (sPLA2) has shown significant antiviral potential against hepatitis C virus (HCV), Japanese encephalitis virus (JEV), and DENV, with IC50 117 ± 43, 49 ± 13, and 183 ± 38 ng/mL, respectively [138].

7. Royal Jelly

Royal jelly (RJ) is a substance enriched with lipids and proteins developed by mandibular and hypopharyngeal bee glands [142]. This bee product is creamy and viscous in nature, with acidic pH of 3.1–3.9 and strong buffering capability (ranging from 4–7). The taste and odor of RJ are slightly bitter and partially water-soluble, having a 1.1 g/mL density [143].

7.1. Composition of Royal Jelly

Royal jelly (Figure 7) is an acidic colloidal substance containing water, carbohydrates, lipids, proteins, minerals, and vitamins [144]. Water is the principal constituent, ranging from 60–70%, followed by 10–18% carbohydrates, 9–18% proteins, 4–8% lipids, and 0.8–3% minerals and vitamins [145]. Glucose and fructose are the most abundant carbohydrates of RJ, followed by sucrose and small amounts of oligosaccharides, including maltose, isomaltose, melibiose, gentiobiose, trehalose, raffinose, ribose, and erlose [146]. The majority of the protein content belongs to apalbumins or the major royal jelly protein (MRJP) family, constituting up to 83–90% of the protein content [147]. The MRJP family contains nine identified proteins, MRJP1, MRJP2, MRJP3, MRJP4, MRJP5, MRJP6, MRJP7, MRJP8, and MRJP9, with 49–87 KDa molecular masses. Proteins other than MRJPs include apismin, apolipophorin III, glucose oxidase, jelleines, royalactina, and royalisin [148].
The lipid components are the unique feature of RJ composition. About 90% of lipids are composed of fatty acids, and the remaining components include waxes (5–6%), phenols (4–10%), steroids (3–4%), and phospholipids (0.4–0.8%) [143,149]. Several vitamins (water-soluble) have been identified in RJ composition. Vitamin B5 (52.80 mg/100 g) [150] is the chief vitamin component of the composition. Other vitamins found in its composition include vitamins B3, B6, E, B2, B1, C, A, B9, D, and B12 with particular amounts of 42.42, 11.90, 5.00, 2.77, 2.06, 2.00, 1.10, 0.40, 0.2, and 0.15 mg/100 g, respectively [151].
The mineral elements include Ca, Cu, Fe, K, Mn, Mg, Na, and Zn. Some trace elements have also been identified, including Cd, Al, Cr, Ba, Co, Bi, Mo, Ni, Sr, Sb, Sn, Hg, V, Pb, Te, Ti, and Tl [143]. Some minor compounds have also been identified, including heterocyclic components, neopterin, and biopterin. Other components are also present in low amounts, such as phosphatase, acetylcholine, free nucleotides (cytidine, adenosine, iridine, and cytidine), AMP, ADP, ATP, and benzoic, citric, lactic, and gluconic acids [144].

7.2. Antiviral Activity of Royal Jelly

Several investigations were found on its potential antibacterial and antifungal activities against various pathogenic microbes. Only a few studies have investigated its antiviral activities, and they showed significant antiviral activities against SARS-CoV-2 [152] and HSV-1 [56]. Another study revealed significant antiviral efficacy against the coxsackievirus by plaque assay [153].

7.3. Adverse Effects of Royal Jelly

Royal jelly can become contaminated with different environmental contaminants, such as carbamates, organochlorines, and organophosphorus (present in pesticides), which have less toxicity. Meanwhile, highly toxic chloramphenicol has also been identified [154]. Consumption of contaminated RJ and its proteins (MRJP-1 and MRJP-2) may induce anaphylaxis, dermatitis, and asthma [155].

8. Beeswax

Beeswax is an intricate compound produced in its liquified form in younger bees aged 12–18 days via particular wax glands. Its color changes from white to yellowish-brown following contact with bee honey and pollen. It partially dissolves in alcohol and completely dissolves in chloroform [32].

8.1. Composition of Beeswax

Beeswax (Figure 8) contains about 300 different components, such as 12–16% hydrocarbons (pentacosane, hentriacosane, heptacosane, nonacosane, and triacosane), 35–45% hydroxymonoesters and linear wax monoesters (basically derived from oleic, 15-hydroxypalmitic, and palmitic acids), 12–14% free fatty acids, 1% fatty alcohols, 15–27% esters and diesters of fatty acids, and some exogenous molecules (residues of pollen and propolis) [156]. Its composition may vary depending upon the different families and bee breeds [157]. Minerals (including Ca, Fe, Mn, P, Cu, K, Na, and Zn) and vitamins (including A, P, B6, B4, and B1) are also beeswax components. Beeswax is also used as an additive in the cosmetic, pharmaceutical, and food industries [158]. Moreover, it has also shown an antimicrobial effect against bacteria (Staphylococcus aureus and Salmonella enterica) and fungi (Aspergillus niger and Candida albicans) [159].

8.2. Antiviral Activity of Beeswax

Only one study evaluated the antiviral potential of four different beeswax extracts and the bee venom, alone and in combination, against DNA (Adeno-7 virus) and RNA (Rift valley fever virus) viruses [160]. According to the results of the study, acetone extract of black beeswax exhibited potent antiviral activity, with a depletion titer of 1.66 log (10)/mL. Ethanol extract of black beeswax also showed moderate activity, while acetone extract of black beeswax showed no antiviral activity.

9. Conclusions

Bee products, including honey, bee venom, propolis, royal jelly, bee bread, and beeswax, have high nutritional importance due to their chemical compositions. However, their consumption is conditioned by possible allergenic action. The increasing therapeutic potential of natural products, particularly bee products, has grabbed the attention of researchers over the last decades. Recent research developments and discernment of the biological properties of bee products and their bioactive compounds, responsible for generating antiviral, antibacterial, antifungal, anticancer, antiparasitic, hepatoprotective, and immunomodulatory effects, need to be extensively assimilated in an effort to upgrade the use of bee products for the management of viral infections and other diseases as well. Bee products contain several bioactive components that possess antiviral properties derived from plant sources. This review demonstrates the highly encouraging antiviral potential of bee products against various viruses. The antiviral components of bee products may often exert antimicrobial activities. Conclusively, this review also suggests that the consumption of bee products, i.e., honey, propolis, bee venom, bee pollen, royal jelly, bee bread, and beeswax, can be an integral approach to enhancing immunity and reducing human health problems.

Author Contributions

Conceptualization, S.T.A., O.B., V.B. and U.A.; literature research, S.R.A.S. and D.A.-A.; original draft preparation, S.T.A.; review and editing of the manuscript, D.A.-A., S.R.A.S., F.R.I. and V.B.; supervision, U.A.; guarantor of the article, O.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

This study is a review, ethical approvals are not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Tafere, D.A. Chemical composition and uses of Honey: A Review. J. Food Sci. Nutr. Res. 2021, 4, 194–201. [Google Scholar] [CrossRef]
  2. Al-Hatamleh, M.A.I.; Boer, J.C.; Wilson, K.L.; Plebanski, M.; Mohamud, R.; Mustafa, M.Z. Antioxidant-Based Medicinal Properties of Stingless Bee Products: Recent Progress and Future Directions. Biomolecules 2020, 10, 923. [Google Scholar] [CrossRef] [PubMed]
  3. Afrin, S.; Haneefa, S.M.; Fernandez-Cabezudo, M.J.; Giampieri, F.; Al-Ramadi, B.K.; Battino, M. Therapeutic and preventive properties of honey and its bioactive compounds in cancer: An evidence-based review. Nutr. Res. Rev. 2019, 33, 50–76. [Google Scholar] [CrossRef] [PubMed]
  4. Olas, B. Bee Products as Interesting Natural Agents for the Prevention and Treatment of Common Cardiovascular Diseases. Nutrients 2022, 14, 2267. [Google Scholar] [CrossRef]
  5. Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021, 71, 209–249. [Google Scholar] [CrossRef]
  6. Moore, P.S.; Chang, Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat. Cancer 2010, 10, 878–889. [Google Scholar] [CrossRef]
  7. Liu, T.; Song, C.; Zhang, Y.; Siyin, S.T.; Zhang, Q.; Song, M.; Cao, L.; Shi, H. Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population: A prospective cohort study. Int. J. Cancer 2021, 150, 1018–1028. [Google Scholar] [CrossRef]
  8. Schiller, J.T.; Lowy, D.R. An introduction to virus infections and human cancer. In Viruses and Human Cancer; Springer: Cham, Switzerland, 2020; pp. 1–11. [Google Scholar] [CrossRef]
  9. Rehman, M.U.; Majid, S. Therapeutic Applications of Honey and its Phytochemicals; Springer: Cham, Switzerland, 2020. [Google Scholar] [CrossRef]
  10. Nweze, J.A.; Olovo, C.V.; Nweze, E.I.; John, O.O.; Paul, C. Therapeutic Properties of Honey. Honey Anal. New Adv. Chall 2020, 1–21. [Google Scholar] [CrossRef]
  11. Almasaudi, S. The antibacterial activities of honey. Saudi J. Biol. Sci. 2020, 28, 2188–2196. [Google Scholar] [CrossRef]
  12. Kamal, D.A.M.; Ibrahim, S.F.; Kamal, H.; Kashim, M.I.A.M.; Mokhtar, M.H. Physicochemical and Medicinal Properties of Tualang, Gelam and Kelulut Honeys: A Comprehensive Review. Nutrients 2021, 13, 197. [Google Scholar] [CrossRef]
  13. Varol, A.; Sezen, S.; Evcimen, D.; Zarepour, A.; Ulus, G.; Zarrabi, A.; Badr, G.; Daştan, S.D.; Orbayoğlu, A.G.; Selamoğlu, Z.; et al. Cellular targets and molecular activity mechanisms of bee venom in cancer: Recent trends and developments. Toxin Rev. 2022, 1–14. [Google Scholar] [CrossRef]
  14. Shehata, M.G.; Ahmad, F.T.; Badr, A.N.; Masry, S.H.; El-Sohaimy, S.A. Chemical analysis, antioxidant, cytotoxic and antimicrobial properties of propolis from different geographic regions. Ann. Agric. Sci. 2020, 65, 209–217. [Google Scholar] [CrossRef]
  15. Bhargava, P.; Mahanta, D.; Kaul, A.; Ishida, Y.; Terao, K.; Wadhwa, R.; Kaul, S. Experimental Evidence for Therapeutic Potentials of Propolis. Nutrients 2021, 13, 2528. [Google Scholar] [CrossRef]
  16. Amoros, M.; Lurton, E.; Boustie, J.; Girre, L.; Sauvager, F.; Cormier, M. Comparison of the anti-herpes simplex virus activities of propolis and 3-methyl-but-2-enyl caffeate. J. Nat. Prod. 1994, 57, 644–647. [Google Scholar] [CrossRef]
  17. Watanabe, K.; Rahmasari, R.; Matsunaga, A.; Haruyama, T.; Kobayashi, N. Anti-influenza Viral Effects of Honey In Vitro: Potent High Activity of Manuka Honey. Arch. Med Res. 2014, 45, 359–365. [Google Scholar] [CrossRef]
  18. Zareie, P.P. Honey as an Antiviral Agent against Respiratory Syncytial Virus; University of Waikato: Hamilton, New Zealand, 2011. [Google Scholar]
  19. Shvarzbeyn, J.; Huleihel, M. Effect of propolis and caffeic acid phenethyl ester (CAPE) on NFκB activation by HTLV-1 Tax. Antivir. Res. 2011, 90, 108–115. [Google Scholar] [CrossRef]
  20. Soroy, L.; Bagus, S.; Yongkie, I.P.; Djoko, W. The effect of a unique propolis compound (Propoelix™) on clinical outcomes in patients with dengue hemorrhagic fever. Infect. Drug Resist. 2014, 7, 323. [Google Scholar] [CrossRef]
  21. Manzoor, M.A.; Chaudhry, Z.I.; Muhammad, K.; Akhtar, R. Amelioration of pathological effects of newcastle disease effected broiler chicks by feeding propolis. Wayamba J. Anim. Sci. 2017, 1511–1517. [Google Scholar]
  22. Lyu, S.Y.; Rhim, J.Y.; Park, W.B. Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2)in vitro. Arch. Pharm. Res. 2005, 28, 1293–1301. [Google Scholar] [CrossRef]
  23. Lee, I.-K.; Hwang, B.S.; Kim, D.-W.; Kim, J.-Y.; Woo, E.-E.; Lee, Y.-J.; Choi, H.J.; Yun, B.-S. Characterization of Neuraminidase Inhibitors in Korean Papaver rhoeas Bee Pollen Contributing to Anti-Influenza Activities In Vitro. Planta Med. 2016, 82, 524–529. [Google Scholar] [CrossRef]
  24. Yosri, N.; El-Wahed, A.A.A.; Ghonaim, R.; Khattab, O.M.; Sabry, A.; Ibrahim, M.A.A.; Moustafa, M.F.; Guo, Z.; Zou, X.; Algethami, A.F.M.; et al. Anti-Viral and Immunomodulatory Properties of Propolis: Chemical Diversity, Pharmacological Properties, Preclinical and Clinical Applications, and In Silico Potential against SARS-CoV-2. Foods 2021, 10, 1776. [Google Scholar] [CrossRef]
  25. Vynograd, N.; Sosnowski, Z. A comparative multi-centre study of the efficacy of propolis, acyclovir and placebo in the treatment of genital herpes (HSV). Phytomedicine 2000, 7, 1–6. [Google Scholar] [CrossRef]
  26. Demir, S.; Atayoglu, A.T.; Galeotti, F.; Garzarella, E.U.; Zaccaria, V.; Volpi, N.; Karagoz, A.; Sahin, F. Antiviral Activity of Different Extracts of Standardized Propolis Preparations against HSV. Antivir. Ther. 2019, 25, 353–363. [Google Scholar] [CrossRef]
  27. Lima, W.G.; Brito, J.C.M.; Nizer, W.S.D.C. Bee products as a source of promising therapeutic and chemoprophylaxis strategies against COVID-19 (SARS-CoV-2). Phytother. Res. 2020, 35, 743–750. [Google Scholar] [CrossRef]
  28. Asfaram, S.; Fakhar, M.; Keighobadi, M.; Akhtari, J. Promising Anti-Protozoan Activities of Propolis (Bee Glue) as Natural Product: A Review. Acta Parasitol. 2020, 66, 1–12. [Google Scholar] [CrossRef]
  29. Mohammed, S.E.A.; Kabashi, A.S.; Koko, W.; Azim, M.K. Antigiardial activity of glycoproteins and glycopeptides fromZiziphushoney. Nat. Prod. Res. 2015, 29, 2100–2102. [Google Scholar] [CrossRef] [PubMed]
  30. Santos-Buelga, C.; González-Paramás, A.M. Phenolic Composition of Propolis. In Bee Products—Chemical and Biological Properties; Alvarez-Suarez, J.M., Ed.; Springer International Publishing: Cham, Switzerland, 2017; pp. 99–111. [Google Scholar] [CrossRef]
  31. Lawal, B.; Shittu, O.; Kabiru, A.; Jigam, A.; Umar, M.; Berinyuy, E.; Alozieuwa, B. Potential antimalarials from African natural products: A review. J. Intercult. Ethnopharmacol. 2015, 4, 318–343. [Google Scholar] [CrossRef] [PubMed]
  32. Fratini, F.; Cilia, G.; Turchi, B.; Felicioli, A. Beeswax: A minireview of its antimicrobial activity and its application in medicine. Asian Pac. J. Trop. Med. 2016, 9, 839–843. [Google Scholar] [CrossRef]
  33. Cornara, L.; Biagi, M.; Xiao, J.; Burlando, B. Therapeutic Properties of Bioactive Compounds from Different Honeybee Products. Front. Pharmacol. 2017, 8, 412. [Google Scholar] [CrossRef] [PubMed]
  34. Meo, S.A.; Al-Asiri, S.A.; Mahesar, A.L.; Ansari, M.J. Role of honey in modern medicine. Saudi J. Biol. Sci. 2016, 24, 975–978. [Google Scholar] [CrossRef] [PubMed]
  35. Liyanage, D.; Mawatha, B. Health benefits and traditional uses of honey: A review. J. Apither. 2017, 2, 9–14. [Google Scholar] [CrossRef]
  36. Santos-Buelga, C.; González-Paramás, A.M. Chemical Composition of Honey. In Bee Products-Chemical and Biological Properties; Springer: Cham, Switzerland, 2017; pp. 43–82. [Google Scholar] [CrossRef]
  37. Kozłowicz, K.; Różyło, R.; Gładyszewska, B.; Matwijczuk, A.; Gładyszewski, G.; Chocyk, D.; Samborska, K.; Piekut, J.; Smolewska, M. Identification of sugars and phenolic compounds in honey powders with the use of GC–MS, FTIR spectroscopy, and X-ray diffraction. Sci. Rep. 2020, 10, 1–10. [Google Scholar] [CrossRef]
  38. Kolayli, S.; Boukraâ, L.; Şahin, H.; Abdellah, F. Sugars in honey. In Dietary Sugars: Chemistry, Analysis, Function and Effects; Royal Society of Chemistry: Cambridge, UK, 2012; pp. 3–15. [Google Scholar] [CrossRef]
  39. Biluca, F.C.; Bernal, J.; Valverde, S.; Ares, A.M.; Gonzaga, L.V.; Costa, A.C.O.; Fett, R. Determination of Free Amino Acids in Stingless Bee (Meliponinae) Honey. Food Anal. Methods 2019, 12, 902–907. [Google Scholar] [CrossRef]
  40. da Silva, P.M.; Gauche, C.; Gonzaga, L.V.; Costa, A.C.O.; Fett, R. Honey: Chemical composition, stability and authenticity. Food Chem. 2016, 196, 309–323. [Google Scholar] [CrossRef]
  41. Suto, M.; Kawashima, H.; Nakamura, Y. Determination of Organic Acids in Honey by Liquid Chromatography with Tandem Mass Spectrometry. Food Anal. Methods 2020, 13, 2249–2257. [Google Scholar] [CrossRef]
  42. Moniruzzaman, M.; Rodríguez, I.; Ramil, M.; Cela, R.; Sulaiman, S.A.; Gan, S.H. Assessment of gas chromatography time-of-flight accurate mass spectrometry for identification of volatile and semi-volatile compounds in honey. Talanta 2014, 129, 505–515. [Google Scholar] [CrossRef]
  43. Mădaş, N.M.; Mărghitaş, L.A.; Dezmirean, D.S.; Bonta, V.; Bobiş, O.; Fauconnier, M.-L.; Francis, F.; Haubruge, E.; Nguyen, K.B. Volatile Profile and Physico-Chemical Analysis of Acacia Honey for Geographical Origin and Nutritional Value Determination. Foods 2019, 8, 445. [Google Scholar] [CrossRef]
  44. Becerril-Sánchez, A.L.; Quintero-Salazar, B.; Dublán-García, O.; Escalona-Buendía, H.B. Phenolic Compounds in Honey and Their Relationship with Antioxidant Activity, Botanical Origin, and Color. Antioxidants 2021, 10, 1700. [Google Scholar] [CrossRef] [PubMed]
  45. Lanjwani, M.F.; Channa, F.A. Minerals content in different types of local and branded honey in Sindh, Pakistan. Heliyon 2019, 5, e02042. [Google Scholar] [CrossRef]
  46. Tutun, H.; Kahraman, H.A.; Aluc, Y.; Avci, T.; Ekici, H. Investigation of some metals in honey samples from West Mediterranean region of Turkey. Veter. Res. Forum Int. Q. J. 2019, 10, 181–186. [Google Scholar] [CrossRef]
  47. Madigan, M.T.; Martinko, J.M.; Bender, K.S.; Buckley, D.H.; Stahl, D.A. Microbiologia de Brock-14ª Edição. Artmed Editora: Porto Alegre, Brazil, 2016. [Google Scholar]
  48. Brooks, G.F.; Carroll, K.C.; Butel, J.S.; Morse, S.A.; Mietzner, T.A. Medical Microbiology, Jawetz, Melnick & Adelbergs, 26th ed.; McGraw-Hill Companies: New York, NY, USA, 2014. [Google Scholar]
  49. Kalediene, L.; Baz, M.; Liubaviciute, A.; Biziuleviciene, G.; Grabauskyte, I.; Bieliauskiene, R.; Jovaisas, P.; Jurjonas, N. Antiviral effect of honey extract Camelyn against SARS-CoV-2. J. Adv. Biotechnol. Exp. Ther. 2021, 4, 290. [Google Scholar] [CrossRef]
  50. Zeina, B.; Othman, O.; Al-Assad, S. Effect of Honey versus Thyme on Rubella Virus Survival In Vitro. J. Altern. Complement. Med. 1996, 2, 345–348. [Google Scholar] [CrossRef] [PubMed]
  51. Hashemipour, M.A.; Tavakolineghad, Z.; Arabzadeh, S.; Iranmanesh, Z.; Nassab, S. Antiviral Activities of Honey, Royal Jelly, and Acyclovir Against HSV-1. Wounds A Compend. Clin. Res. Pract. 2014, 26, 47–54. [Google Scholar]
  52. Charyasriwong, S.; Haruyama, T.; Kobayashi, N. In vitro evaluation of the antiviral activity of methylglyoxal against influenza B virus infection. Drug Discov. Ther. 2016, 10, 201–210. [Google Scholar] [CrossRef]
  53. Semprini, A.; Singer, J.; Braithwaite, I.; Shortt, N.; Thayabaran, D.; McConnell, M.; Weatherall, M.; Beasley, R. Kanuka honey versus aciclovir for the topical treatment of herpes simplex labialis: A randomised controlled trial. BMJ Open 2019, 9, e026201. [Google Scholar] [CrossRef]
  54. Sobhanian, S.; Pourahmad, M.; Jafarzadeh, A.; Tadayon, S.M.K.; Zabetian, H. The prophylactic effect of honey on common cold. Quran Med. 2014, 3, 10111. [Google Scholar] [CrossRef]
  55. Yusuf, W.N.W.; Mohammad, W.M.Z.W.; Gan, S.H.; Mustafa, M.; Aziz, C.B.A.; Sulaiman, S.A. Tualang honey ameliorates viral load, CD4 counts and improves quality of life in asymptomatic human immunodeficiency virus infected patients. J. Tradit. Complement. Med. 2018, 9, 249–256. [Google Scholar] [CrossRef]
  56. Behbahani, M. Anti-HIV-1 Activity of Eight Monofloral Iranian Honey Types. PLoS ONE 2014, 9, e108195. [Google Scholar] [CrossRef]
  57. Ghapanchi, J.; Moattari, A.; Tadbir, A.A.; Talatof, Z.; Shahidi, S.P.; Ebrahimi, H. The in vitro anti-viral activity of honey on type 1 herpes simplex virus. Aust. J. Basic Appl. Sci. 2011, 5, 849–852. [Google Scholar]
  58. Vahed, H.; Jafri, S.B. Propagation of Influenza Virus in Lymphocytes Determine by Antiviral Effects of Honey, Ginger and Garlic Decoction. J. Antivirals Antiretrovir. 2016, 8, 1000129. [Google Scholar] [CrossRef]
  59. Littlejohn, E.S.V. The Sensitivity of Adenovirus and Herpes simplex virus to Honey; The University of Waikato: Hamilton, New Zealand, 2009. [Google Scholar]
  60. Al-Waili, N.S. Topical honey application vs. acyclovir for the treatment of recurrent herpes simplex lesions. Med. Sci. Monit. 2004, 10, MT94-98. [Google Scholar] [PubMed]
  61. Münstedt, K. Bee products and the treatment of blister-like lesions around the mouth, skin and genitalia caused by herpes viruses—A systematic review. Complement. Ther. Med. 2019, 43, 81–84. [Google Scholar] [CrossRef]
  62. Shahzad, A.; Cohrs, R.J. International Archives of Medicine. Transl. Biomed. 2015, 3, 434. [Google Scholar] [CrossRef]
  63. Thompson, W.W.; Shay, D.K.; Weintraub, E.; Brammer, L.; Cox, N.; Anderson, L.J.; Fukuda, K. Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States. JAMA J. Am. Med Assoc. 2003, 289, 179–186. [Google Scholar] [CrossRef]
  64. Shimizu, T.; Hino, A.; Tsutsumi, A.; Park, Y.K.; Watanabe, W.; Kurokawa, M. Anti-Influenza Virus Activity of Propolis In Vitro and Its Efficacy against Influenza Infection in Mice. Antivir. Chem. Chemother. 2008, 19, 7–13. [Google Scholar] [CrossRef]
  65. Lucatello, L.; Piana, L.; Fasolato, L.; Capolongo, F. A multivariate statistical approach to identify the factors influencing the grayanotoxin content of Italian Rhododendron honey. Food Control 2022, 136, 108881. [Google Scholar] [CrossRef]
  66. Sinha, S.; Jothiramajayam, M.; Ghosh, M.; Jana, A.; Chatterji, U.; Mukherjee, A. Vetiver oil (Java) attenuates cisplatin-induced oxidative stress, nephrotoxicity and myelosuppression in Swiss albino mice. Food Chem. Toxicol. 2015, 81, 120–128. [Google Scholar] [CrossRef]
  67. Koca, I.; Koca, A.F. Poisoning by mad honey: A brief review. Food Chem. Toxicol. 2007, 45, 1315–1318. [Google Scholar] [CrossRef]
  68. Brugnerotto, P.; Seraglio, S.K.T.; Schulz, M.; Gonzaga, L.V.; Fett, R.; Costa, A.C.O. Pyrrolizidine alkaloids and beehive products: A review. Food Chem. 2020, 342, 128384. [Google Scholar] [CrossRef]
  69. Yan, S.; Wang, K.; Al Naggar, Y.; Heyden, Y.V.; Zhao, L.; Wu, L.; Xue, X. Natural plant toxins in honey: An ignored threat to human health. J. Hazard. Mater. 2021, 424, 127682. [Google Scholar] [CrossRef]
  70. Larsen, L.; Joyce, N.I.; Sansom, C.E.; Cooney, J.M.; Jensen, D.J.; Perry, N.B. Sweet Poisons: Honeys Contaminated with Glycosides of the Neurotoxin Tutin. J. Nat. Prod. 2015, 78, 1363–1369. [Google Scholar] [CrossRef] [PubMed]
  71. Fields, B.A.; Reeve, J.; Bartholomaeus, A.; Mueller, U. Human pharmacokinetic study of tutin in honey; a plant-derived neurotoxin. Food Chem. Toxicol. 2014, 72, 234–241. [Google Scholar] [CrossRef] [PubMed]
  72. Yang, S.; Liu, Y.; Sun, F.; Zhang, J.; Jin, Y.; Li, Y.; Zhou, J.; Li, Y.; Zhu, K. Gelsedine-type alkaloids: Discovery of natural neurotoxins presented in toxic honey. J. Hazard. Mater. 2019, 381, 120999. [Google Scholar] [CrossRef] [PubMed]
  73. Thakur, M.; Nanda, V. Composition and functionality of bee pollen: A review. Trends Food Sci. Technol. 2020, 98, 82–106. [Google Scholar] [CrossRef]
  74. Saavedra, C.I.; Rojas, I.C.; Delgado, P.G.E. Características polínicas y composición química del polen apícola colectado en Cayaltí (Lambayeque-Perú). Rev. Chil. Nutr. 2013, 40, 71–78. [Google Scholar] [CrossRef]
  75. Komosinska-Vassev, K.; Olczyk, P.; Kaźmierczak, J.; Mencner, L.; Olczyk, K. Bee Pollen: Chemical Composition and Therapeutic Application. Evid. Based Complement. Altern. Med. 2015, 2015, 297425. [Google Scholar] [CrossRef]
  76. Khalifa, S.; Elashal, M.; Yosri, N.; Du, M.; Musharraf, S.; Nahar, L.; Sarker, S.; Guo, Z.; Cao, W.; Zou, X.; et al. Bee Pollen: Current Status and Therapeutic Potential. Nutrients 2021, 13, 1876. [Google Scholar] [CrossRef]
  77. Mărgăoan, R.; Özkök, A.; Keskin, Ş.; Mayda, N.; Urcan, A.C.; Cornea-Cipcigan, M. Bee collected pollen as a value-added product rich in bioactive compounds and unsaturated fatty acids: A comparative study from Turkey and Romania. LWT 2021, 149, 111925. [Google Scholar] [CrossRef]
  78. De-Melo, A.A.M.; De Almeida-Muradian, L.B. Chemical Composition of Bee Pollen. In Bee products-Chemical and Biological Properties; Springer: Cham, Switzerland, 2017; pp. 221–259. [Google Scholar] [CrossRef]
  79. Sattler, J.A.G.; de Melo, I.L.P.; Granato, D.; Araújo, E.; Freitas, A.D.S.D.; Barth, O.M.; Sattler, A.; de Almeida-Muradian, L.B. Impact of origin on bioactive compounds and nutritional composition of bee pollen from southern Brazil: A screening study. Food Res. Int. 2015, 77, 82–91. [Google Scholar] [CrossRef]
  80. Souza, B.R.d. Quantificação das Vitaminas do Complexo B (B1, B2) e Vitâmeros das Vitaminas B3 e B6 em Amostras de pólen apícola Desidratado Provenientes da Região Sul do Brasil; Universidade de São Paulo: São Paulo, Brazil, 2017. [Google Scholar]
  81. Melo, A.A.M.d. Perfil Químico e Microbiológico, cor, Análise Polínica e Propriedades Biológicas do Pólen Apícola Desidratado; Universidade de São Paulo: São Paulo, Brazil, 2017. [Google Scholar]
  82. Yang, K.; Wu, D.; Ye, X.; Liu, D.; Chen, J.; Sun, P. Characterization of Chemical Composition of Bee Pollen in China. J. Agric. Food Chem. 2013, 61, 708–718. [Google Scholar] [CrossRef]
  83. Youssef, A.M.; Farag, R.S.; Ewies, M.A.; El-Shakaa, S.M.A. Chemical Studies on Pollen Collected by Honeybees in Giza Region, Egypt. J. Apic. Res. 1978, 17, 110–113. [Google Scholar] [CrossRef]
  84. Nogueira, C.; Iglesias, A.; Feás, X.; Estevinho, L.M. Commercial Bee Pollen with Different Geographical Origins: A Comprehensive Approach. Int. J. Mol. Sci. 2012, 13, 11173–11187. [Google Scholar] [CrossRef]
  85. Féas, X.; Vázquez-Tato, M.P.; Estevinho, L.; Seijas, J.A.; Iglesias, A. Organic Bee Pollen: Botanical Origin, Nutritional Value, Bioactive Compounds, Antioxidant Activity and Microbiological Quality. Molecules 2012, 17, 8359–8377. [Google Scholar] [CrossRef]
  86. Kostić, A.; Barać, M.B.; Stanojević, S.P.; Milojković-Opsenica, D.M.; Tešić, L.; Šikoparija, B.; Radišić, P.; Prentović, M.; Pešić, M.B. Physicochemical composition and techno-functional properties of bee pollen collected in Serbia. LWT 2015, 62, 301–309. [Google Scholar] [CrossRef]
  87. Fuenmayor, B.C.; Zuluaga, D.C.; Díaz, M.C.; de Quicazán, C.M.; Cosio, M.; Mannino, S. Evaluation of the physicochemical and functional properties of Colombian bee pollen. Rev. MVZ Córdoba 2014, 19, 4003–4014. [Google Scholar] [CrossRef]
  88. Almeida-Muradian, L.; Pamplona, L.C.; Coimbra, S.; Barth, O.M. Chemical composition and botanical evaluation of dried bee pollen pellets. J. Food Compos. Anal. 2005, 18, 105–111. [Google Scholar] [CrossRef]
  89. Mayda, N.; Özkök, A.; Bayram, N.E.; Gerçek, Y.C.; Sorkun, K. Bee bread and bee pollen of different plant sources: Determination of phenolic content, antioxidant activity, fatty acid and element profiles. J. Food Meas. Charact. 2020, 14, 1795–1809. [Google Scholar] [CrossRef]
  90. Campos, M.; Markham, K.R.; Mitchell, K.A.; da Cunha, A.P. An approach to the characterization of bee pollens via their flavonoid/phenolic profiles. Phytochem. Anal. 1997, 8, 181–185. [Google Scholar] [CrossRef]
  91. Mărgăoan, R.; Mărghitaş, L.A.; Dezmirean, D.S.; Dulf, F.V.; Bunea, A.; Socaci, S.A.; Bobiş, O. Predominant and Secondary Pollen Botanical Origins Influence the Carotenoid and Fatty Acid Profile in Fresh Honeybee-Collected Pollen. J. Agric. Food Chem. 2014, 62, 6306–6316. [Google Scholar] [CrossRef]
  92. Inacio, L.D.J.; Merlanti, R.; Lucatello, L.; Bisutti, V.; Contiero, B.; Serva, L.; Segato, S.; Capolongo, F. Pyrrolizidine alkaloids in bee pollen identified by LC-MS/MS analysis and colour parameters using multivariate class modeling. Heliyon 2020, 6, e03593. [Google Scholar] [CrossRef]
  93. Végh, R.; Csóka, M.; Sörös, C.; Sipos, L. Food safety hazards of bee pollen—A review. Trends Food Sci. Technol. 2021, 114, 490–509. [Google Scholar] [CrossRef]
  94. Zafeiraki, E.; Kasiotis, K.M.; Nisianakis, P.; Manea-Karga, E.; Machera, K. Occurrence and human health risk assessment of mineral elements and pesticides residues in bee pollen. Food Chem. Toxicol. 2022, 161, 112826. [Google Scholar] [CrossRef] [PubMed]
  95. Bakour, M.; Fernandes, Â.; Barros, L.; Sokovic, M.; Ferreira, I.C.F.R.; Lyoussi, B. Bee bread as a functional product: Chemical composition and bioactive properties. LWT 2019, 109, 276–282. [Google Scholar] [CrossRef]
  96. Mohammad, S.M.; Mahmud-Ab-Rashid, N.-K.; Zawawi, N. Botanical Origin and Nutritional Values of Bee Bread of Stingless Bee (Heterotrigona itama) from Malaysia. J. Food Qual. 2020, 2020, 2845757. [Google Scholar] [CrossRef]
  97. Nagai, T.; Nagashima, T.; Myoda, T.; Inoue, R. Preparation and functional properties of extracts from bee bread. Food Nahr. 2004, 48, 226–229. [Google Scholar] [CrossRef]
  98. Urcan, A.C.; Criste, A.D.; Dezmirean, D.S.; Bobiș, O.; Bonta, V.; Dulf, F.V.; Mărgăoan, R.; Cornea-Cipcigan, M.; Campos, M.G. Botanical origin approach for a better understanding of chemical and nutritional composition of beebread as an important value-added food supplement. LWT 2021, 142, 111068. [Google Scholar] [CrossRef]
  99. Kaplan, M.; Karaoglu, Ö.; Eroglu, N.; Silici, S. Fatty Acids and Proximate Composition of Beebread. Food Technol. Biotechnol. 2016, 54, 497–504. [Google Scholar] [CrossRef]
  100. Pełka, K.; Otłowska, O.; Worobo, R.; Szweda, P. Bee Bread Exhibits Higher Antimicrobial Potential Compared to Bee Pollen. Antibiotics 2021, 10, 125. [Google Scholar] [CrossRef]
  101. Didaras, N.A.; Karatasou, K.; Dimitriou, T.G.; Amoutzias, G.D.; Mossialos, D. Antimicrobial Activity of Bee-Collected Pollen and Beebread: State of the Art and Future Perspectives. Antibiotics 2020, 9, 811. [Google Scholar] [CrossRef]
  102. Didaras, N.A.; Dimitriou, T.; Daskou, M.; Karatasou, K.; Mossialos, D. In Vitro Assessment of the Antiviral Activity of Greek Bee Bread and Bee Collected Pollen against Enterovirus D68. J. Microbiol. Biotechnol. Food Sci. 2022, 11, e4859. [Google Scholar] [CrossRef]
  103. Chen, Y.-W.; Ye, S.-R.; Ting, C.; Yu, Y.-H. Antibacterial activity of propolins from Taiwanese green propolis. J. Food Drug Anal. 2018, 26, 761–768. [Google Scholar] [CrossRef]
  104. Costa, A.S.; Machado, B.A.S.; Umsza-Guez, M.A.; Cirqueira, M.G.; Nunes, S.B.; Padilha, F.F. Survey of studies with propolis produced in the state of Bahia, Brazil. SITIENTIBUS Série Ciências Biológicas 2013, 13, 1–7. [Google Scholar] [CrossRef]
  105. Huang, S.; Zhang, C.-P.; Wang, K.; Li, G.Q.; Hu, F.-L. Recent Advances in the Chemical Composition of Propolis. Molecules 2014, 19, 19610–19632. [Google Scholar] [CrossRef]
  106. Şahinler, N.; Kaftanoglu, O. Natural product propolis: Chemical composition. Nat. Prod. Res. 2005, 19, 183–188. [Google Scholar] [CrossRef] [PubMed]
  107. Ristivojevic, P.; Trifkovic, J.; Andric, F.; Milojković-Opsenica, D. Poplar-type Propolis: Chemical Composition, Botanical Origin and Biological Activity. Nat. Prod. Commun. 2015, 10, 1869–1876. [Google Scholar] [CrossRef]
  108. Marcucci, M.C. Propolis: Chemical composition, biological properties and therapeutic activity. Apidologie 1995, 26, 83–99. [Google Scholar] [CrossRef]
  109. Sforcin, J.M. Biological Properties and Therapeutic Applications of Propolis. Phytother. Res. 2016, 30, 894–905. [Google Scholar] [CrossRef]
  110. González-Búrquez, M.D.J.; González-Díaz, F.R.; García-Tovar, C.G.; Carrillo-Miranda, L.; Soto-Zárate, C.I.; Canales-Martínez, M.M.; Penieres-Carrillo, J.G.; Crúz-Sánchez, T.A.; Fonseca-Coronado, S. Comparison between In Vitro Antiviral Effect of Mexican Propolis and Three Commercial Flavonoids against Canine Distemper Virus. Evid.-Based Complement. Altern. Med. 2018, 2018, 7092416. [Google Scholar] [CrossRef]
  111. Schnitzler, P.; Neuner, A.; Nolkemper, S.; Zundel, C.; Nowack, H.; Sensch, K.H.; Reichling, J. Antiviral Activity and Mode of Action of Propolis Extracts and Selected Compounds. Phytother. Res. 2010, 24 (Suppl. 1), S20–S28. [Google Scholar] [CrossRef] [PubMed]
  112. Harish, Z.; Rubinstein, A.; Golodner, M.; Elmaliah, M.; Mizrachi, Y. Suppression of HIV-1 replication by propolis and its immunoregulatory effect. Drugs Under Exp. Clin. Res. 1997, 23, 89–96. [Google Scholar]
  113. Kwon, M.J.; Shin, H.M.; Perumalsamy, H.; Wang, X.; Ahn, Y.-J. Antiviral effects and possible mechanisms of action of constituents from Brazilian propolis and related compounds. J. Apic. Res. 2019, 59, 413–425. [Google Scholar] [CrossRef]
  114. Huleihel, M.; Isanu, V. Anti-herpes simplex virus effect of an aqueous extract of propolis. Isr. Med. Assoc. J. IMAJ 2002, 4, 923–927. [Google Scholar] [PubMed]
  115. Labska, K.; Plodkova, H.; Pumannova, M.; Sensch, K.H. Antiviral activity of propolis special extract GH 2002 against Varicella zoster virus in vitro. Pharmazie 2018, 73, 733–736. [Google Scholar] [CrossRef] [PubMed]
  116. Bankova, V.; Galabov, A.; Antonova, D.; Vilhelmova, N.; Di Perri, B. Chemical composition of Propolis Extract ACF® and activity against herpes simplex virus. Phytomedicine 2014, 21, 1432–1438. [Google Scholar] [CrossRef]
  117. Amoros, M.; Sauvager, F.; Girre, L.; Cormier, M. In vitro antiviral activity of propolis. Apidologie 1992, 23, 231–240. [Google Scholar] [CrossRef]
  118. Amoros, M.; Simõs, C.M.O.; Girre, L.; Sauvager, F.; Cormier, M. Synergistic Effect of Flavones and Flavonols Against Herpes Simplex Virus Type 1 in Cell Culture. Comparison with the Antiviral Activity of Propolis. J. Nat. Prod. 1992, 55, 1732–1740. [Google Scholar] [CrossRef]
  119. Fokt, H.; Pereira, A.; Ferreira, A.; Cunha, A.; Aguiar, C. How do bees prevent hive infections? The antimicrobial properties of propolis. In Current Research, Technology and Education Topics in Applied Microbiology and Microbial Biotechnology; FORMATEX: Badajoz, Spain, 2010; pp. 481–493. [Google Scholar]
  120. Nolkemper, S.; Reichling, J.; Sensch, K.H.; Schnitzler, P. Mechanism of herpes simplex virus type 2 suppression by propolis extracts. Phytomedicine 2010, 17, 132–138. [Google Scholar] [CrossRef]
  121. Siheri, W.; Alenezi, S.; Tusiimire, J.; Watson, D.G. The Chemical and Biological Properties of Propolis. In Bee Products-Chemical and Biological Properties; Alvarez-Suarez, J., Ed.; Springer: Cham, Switzerland, 2017; pp. 137–178. [Google Scholar]
  122. Abd El Hady, F.K.; Hegazi, A.G. Egyptian propolis: 2. Chemical composition, antiviral and antimicrobial activities of East Nile Delta propolis. Z. Naturforsch. C. J. Biosci. 2002, 57, 386–394. [Google Scholar] [CrossRef]
  123. Coelho, G.R.; Mendonça, R.Z.; Vilar, K.D.S.; Figueiredo, C.A.; Badari, J.C.; Taniwaki, N.; Namiyama, G.; de Oliveira, M.I.; Curti, S.P.; Silva, P.E.; et al. Antiviral Action of Hydromethanolic Extract of Geopropolis from Scaptotrigona postica against Antiherpes Simplex Virus (HSV-1). Evid. Based Complement. Altern. Med. 2015, 2015, 296086. [Google Scholar] [CrossRef]
  124. Yildirim, A.; Duran, G.G.; Duran, N.; Jenedi, K.; Bolgul, B.S.; Miraloglu, M.; Muz, M. Antiviral Activity of Hatay Propolis Against Replication of Herpes Simplex Virus Type 1 and Type 2. Med. Sci. Monit. 2016, 22, 422–430. [Google Scholar] [CrossRef]
  125. Ozcan, H.; Ulkevan, T.; Özcan, T.H. Propolis Induced Mania with Psychotic Features: A Case Report. Klin. Psikofarmakol. Bülteni-Bull. Clin. Psychopharmacol. 2015, 25, 207. [Google Scholar] [CrossRef]
  126. Nyman, G.; Wagner, S.; Prystupa-Chalkidis, K.; Ryberg, K.; Hagvall, L. Contact Allergy in Western Sweden to Propolis of Four Different Origins. Acta Derm. Venereol. 2020, 100, adv00256. [Google Scholar] [CrossRef]
  127. Abd El-Wahed, A.A.; Khalifa, S.A.M.; Sheikh, B.Y.; Farag, M.A.; Saeed, A.; Larik, F.A.; Koca-Caliskan, U.; AlAjmi, M.F.; Hassan, M.; Wahabi, H.A.; et al. Bee Venom Composition: From Chemistry to Biological Activity. Stud. Nat. Prod. Chem. 2018, 60, 459–484. [Google Scholar] [CrossRef]
  128. Kim, J.-Y.; Kim, K.-H.; Lee, W.-R.; An, H.-J.; Lee, S.-J.; Han, S.-M.; Lee, K.-G.; Park, Y.-Y.; Kim, K.-S.; Lee, Y.-S.; et al. Apamin inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration through suppressions of activated Akt and Erk signaling pathway. Vasc. Pharmacol. 2015, 70, 8–14. [Google Scholar] [CrossRef]
  129. Banks, B.E.; Shipolini, R.A. Chemistry and pharmacology of honey-bee venom. In Venoms of the Hymenoptera: Biochemical, Pharmacological and Behavioural Aspects; Academic Press: London, UK, 1986; pp. 329–416. [Google Scholar]
  130. Pak, S.C. Chemical Composition of Bee Venom. In Bee Products-Chemical and Biological Properties; Springer: Cham, Switzerland, 2017; pp. 279–285. [Google Scholar] [CrossRef]
  131. Chen, J.; Guan, S.-M.; Sun, W.; Fu, H. Melittin, the Major Pain-Producing Substance of Bee Venom. Neurosci. Bull. 2016, 32, 265–272. [Google Scholar] [CrossRef]
  132. Moreno, M.; Giralt, E. Three Valuable Peptides from Bee and Wasp Venoms for Therapeutic and Biotechnological Use: Melittin, Apamin and Mastoparan. Toxins 2015, 7, 1126–1150. [Google Scholar] [CrossRef]
  133. Dotimas, E.M.; Hider, R.C. Honeybee Venom. Bee World 1987, 68, 51–70. [Google Scholar] [CrossRef]
  134. Bellik, Y. Bee venom: Its potential use in alternative medicine. Anti-Infect. Agents 2015, 13, 3–16. [Google Scholar] [CrossRef]
  135. El-Seedi, H.; El-Wahed, A.A.; Yosri, N.; Musharraf, S.G.; Chen, L.; Moustafa, M.; Zou, X.; Al-Mousawi, S.; Guo, Z.; Khatib, A.; et al. Antimicrobial Properties of Apis mellifera’s Bee Venom. Toxins 2020, 12, 451. [Google Scholar] [CrossRef]
  136. Uddin, M.B.; Lee, B.-H.; Nikapitiya, C.; Kim, J.-H.; Kim, T.-H.; Lee, H.-C.; Kim, C.G.; Lee, J.-S.; Kim, C.-J. Inhibitory effects of bee venom and its components against viruses in vitro and in vivo. J. Microbiol. 2016, 54, 853–866. [Google Scholar] [CrossRef]
  137. Lee, J.-A.; Kim, Y.-M.; Hyun, P.-M.; Jeon, J.-W.; Park, J.-K.; Suh, G.-H.; Jung, B.-G.; Lee, B.-J. Honeybee (Apis mellifera) Venom Reinforces Viral Clearance during the Early Stage of Infection with Porcine Reproductive and Respiratory Syndrome Virus through the Up-Regulation of Th1-Specific Immune Responses. Toxins 2015, 7, 1837–1853. [Google Scholar] [CrossRef] [PubMed]
  138. Chen, M.; Aoki-Utsubo, C.; Kameoka, M.; Deng, L.; Terada, Y.; Kamitani, W.; Sato, K.; Koyanagi, Y.; Hijikata, M.; Shindo, K.; et al. Broad-spectrum antiviral agents: Secreted phospholipase A2 targets viral envelope lipid bilayers derived from the endoplasmic reticulum membrane. Sci. Rep. 2017, 7, 1–8. [Google Scholar] [CrossRef]
  139. Kamal, S.A. In Vitro Study on the Effect of Bee Venom on Some Cell Lines and Lumpy Skin Disease Virus. J. Agric. Sci. Technol. A 2016, 6, 124–135. [Google Scholar] [CrossRef]
  140. Kim, Y.-W.; Chaturvedi, P.K.; Chun, S.N.; Lee, Y.G.; Ahn, W.S. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line. Oncol. Rep. 2015, 33, 1675–1682. [Google Scholar] [CrossRef] [PubMed]
  141. Fenard, D.; Lambeau, G.; Maurin, T.; Lefebvre, J.-C.; Doglio, A. A Peptide Derived from Bee Venom-Secreted Phospholipase A2 Inhibits Replication of T-Cell Tropic HIV-1 Strains via Interaction with the CXCR4 Chemokine Receptor. Mol. Pharmacol. 2001, 60, 341–347. [Google Scholar] [CrossRef] [PubMed]
  142. Fujita, T.; Kozuka-Hata, H.; Ao-Kondo, H.; Kunieda, T.; Oyama, M.; Kubo, T. Proteomic Analysis of the Royal Jelly and Characterization of the Functions of its Derivation Glands in the Honeybee. J. Proteome Res. 2012, 12, 404–411. [Google Scholar] [CrossRef] [PubMed]
  143. Nabas, Z.; Haddadin, M.S.; Haddadin, J.; Nazer, I.K. Chemical Composition of Royal Jelly and Effects of Synbiotic with Two Different Locally Isolated Probiotic Strains on Antioxidant Activities. Pol. J. Food Nutr. Sci. 2014, 64, 171–180. [Google Scholar] [CrossRef]
  144. El-Guendouz, S.; Lyoussi, B.; Miguel, M.G. Insight into the chemical composition and biological properties of Mediterranean royal jelly. J. Apic. Res. 2020, 59, 890–909. [Google Scholar] [CrossRef]
  145. Balkanska, R.; Karadjova, I.; Ignatova, M. Comparative analyses of chemical composition of royal jelly and drone brood. Bulg. Chem. Commun. 2014, 46, 412–416. [Google Scholar]
  146. Lercker, G.; Savioli, S.; Vecchi, M.; Sabatini, A.; Nanetti, A.; Piana, L. Carbohydrate determination of Royal Jelly by high resolution gas chromatography (HRGC). Food Chem. 1986, 19, 255–264. [Google Scholar] [CrossRef]
  147. Šimúth, J. Some properties of the main protein of honeybee (Apis mellifera) royal jelly. Apidologie 2001, 32, 69–80. [Google Scholar] [CrossRef]
  148. Ramanathan, A.N.K.G.; Nair, A.J.; Sugunan, V.S. A review on Royal Jelly proteins and peptides. J. Funct. Foods 2018, 44, 255–264. [Google Scholar] [CrossRef]
  149. Li, X.; Huang, C.; Xue, Y. Contribution of Lipids in Honeybee (Apis mellifera) Royal Jelly to Health. J. Med. Food 2013, 16, 96–102. [Google Scholar] [CrossRef]
  150. Ciulu, M.; Floris, I.; Nurchi, V.M.; Panzanelli, A.; Pilo, M.I.; Spano, N.; Sanna, G. HPLC determination of pantothenic acid in royal jelly. Anal. Methods 2013, 5, 6682–6685. [Google Scholar] [CrossRef]
  151. Bogdanov, S. Royal jelly, bee brood: Composition, health, medicine: A review. Lipids 2011, 3, 8–19. [Google Scholar]
  152. Habashy, N.H.; Abu-Serie, M.M. The potential antiviral effect of major royal jelly protein2 and its isoform X1 against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Insight on their sialidase activity and molecular docking. J. Funct. Foods 2020, 75, 104282. [Google Scholar] [CrossRef]
  153. Stocker, A. Isolation and Characterisation of Substances from Royal Jelly; Technische Universität München: Munich, Germany, 2003. [Google Scholar]
  154. Rizzo, S.; Russo, M.; Labra, M.; Campone, L.; Rastrelli, L. Determination of Chloramphenicol in Honey Using Salting-Out Assisted Liquid-Liquid Extraction Coupled with Liquid Chromatography-Tandem Mass Spectrometry and Validation According to 2002/657 European Commission Decision. Molecules 2020, 25, 3481. [Google Scholar] [CrossRef]
  155. Hata, T.; Furusawa-Horie, T.; Arai, Y.; Takahashi, T.; Seishima, M.; Ichihara, K. Studies of royal jelly and associated cross-reactive allergens in atopic dermatitis patients. PLoS ONE 2020, 15, e0233707. [Google Scholar] [CrossRef]
  156. Tulloch, A.P. Beeswax—Composition and Analysis. Bee World 1980, 61, 47–62. [Google Scholar] [CrossRef]
  157. Bogdanov, S. Beeswax: Quality issues today. Bee World 2004, 85, 46–50. [Google Scholar] [CrossRef]
  158. Velickova, E.; Winkelhausen, E.; Kuzmanova, S.; Moldao-Martins, M.; Alves, V.D. Characterization of multilayered and composite edible films from chitosan and beeswax. Food Sci. Technol. Int. 2015, 21, 83–93. [Google Scholar] [CrossRef] [PubMed]
  159. Abdulrhman, M.; Samir Elbarbary, N.; Ahmed Amin, D.; Saeid Ebrahim, R. Honey and a mixture of honey, beeswax, and olive oil–propolis extract in treatment of chemotherapy-induced oral mucositis: A randomized controlled pilot study. Pediatr. Hematol. Oncol. 2012, 29, 285–292. [Google Scholar] [CrossRef] [PubMed]
  160. Hassan, M.I.; Mohamed, A.; Amer, M.A.; Hammad, K.M.; Riad, S.A. Monitoring of the antiviral potential of bee venom and wax extracts against Adeno-7 (DNA) and Rift Valley fever virus (RNA) viruses models. J. Egypt. Soc. Parasitol. 2015, 45, 193–198. [Google Scholar] [CrossRef]
Figure 1. Antiviral properties of bee products.
Figure 1. Antiviral properties of bee products.
Nutrients 14 03579 g001
Figure 2. General composition of honey.
Figure 2. General composition of honey.
Nutrients 14 03579 g002
Figure 3. Chemical structures of some important phenolic components in honey; (A) flavonoids and (B) phenolic acids.
Figure 3. Chemical structures of some important phenolic components in honey; (A) flavonoids and (B) phenolic acids.
Nutrients 14 03579 g003
Figure 4. Honey and its components general mode of action against viruses.
Figure 4. Honey and its components general mode of action against viruses.
Nutrients 14 03579 g004
Figure 5. Main identified constituents of bee pollen and bee bread.
Figure 5. Main identified constituents of bee pollen and bee bread.
Nutrients 14 03579 g005
Figure 6. General composition of propolis.
Figure 6. General composition of propolis.
Nutrients 14 03579 g006
Figure 7. General composition of royal jelly.
Figure 7. General composition of royal jelly.
Nutrients 14 03579 g007
Figure 8. General composition of beeswax.
Figure 8. General composition of beeswax.
Nutrients 14 03579 g008
Table 1. Antiviral activities of honey and its components.
Table 1. Antiviral activities of honey and its components.
Honey or Its CompoundsOrganismTested ModelOutcome of the StudyReferences
Honey extract (Camelyn)SARS-CoV-2In vitro (plaque reduction assay) baby hamster kidney cell line 21 (BHK-21), bone marrow-derived hematopoietic stem cells (HSCs), and splenic cellsShowed an inhibitory effect with an EC50 value from 85.7 μg/mL to 192.4 μg/mL.[49]
HoneyRubella virusIn vitro African green monkey kidney cellsInhibited the virus at all concentrations (1:1 to 1:1000 dilutions).[50]
HoneyHSV-1In vitro (plaque assay technique) Vero cellsShowed the highest inhibitory effect at 500 μg/mL and reduced viral load from 70795 to 43.3.[51]
Methylglyoxal
(Component of manuka honey)
Influenza B virusIn vitro
Madin-Darby canine kidney cells
Inhibited influenza B virus replication, with 50% inhibitory concentrations ranging from 23–140 μM.[52]
Kanuka honeyHerpes simplex labialisHuman model: 952 adults participated to compare the effect of Kanuka honey to 5% aciclovir creamThere was no difference in effectiveness compared with 5% acyclovir.[53]
HoneyCommon coldHuman model (cohort study): 122 students participatedEspecially after six weeks of honey application, common cold frequency was lower than in the control group.[54]
Tualang honeyHIVHuman model: 95 asymptomatic HIV-positive subjects participatedAmeliorated CD4 count, viral load, and quality of life. [55]
Iranian honeys (8 monofloral honey types obtained from Petro selinum sativum, Nigella sativa, Citrus sinensis, Zataria multiflora, Citrus aurantium, Zizyphus mauritiana, Astragalus gummifer, and Chamaemelum nobile flowers)HIV-1In vitro peripheral blood mononuclear cells Showed potent anti-HIV-1 activity in 6 of 8 monofloral honeys with EC50 values ranging from 5 to 105 µg/mL.[56]
HoneyHSV-1In vitro Vero cells Showed complete inhibitory effect at 5% and higher concentrations.[57]
Honey (garlic and ginger decoction) Influenza virusIn vitro human peripheral blood mononuclear cells Decreased replication of the H1N2.[58]
Honeydew, manuka, and rewarewa honey Adenovirus, rubella virus, and HSVIn vitroIncreased antiviral activity with the concentration of honey and time the virus was exposed to it.[59]
Table 2. Protein content of bee pollen originating from different countries.
Table 2. Protein content of bee pollen originating from different countries.
CountryOriginProtein Content (g/100 g)References
BrazilHeterofloral8.4–40.5[79]
Brassica napus23.0–24.5[80]
Mimosa scabrella11.7–33.9[81]
Mimosa caesalpiniaefolia17.6–21.2
ChinaCitrullus lanatus20.7[82]
Fagopyrum esculentum14.3
Helianthus annuus15.3
Dendranthema indicum14.9
EgyptBrassica kaber29.0[83]
Zea mays23.3
Trifolium alexandrium35.5
PortugalHeterofloral18.8–34.2[84]
Cistus23.0–27.1[85]
SerbiaHeterofloral14.8–27.2[86]
Fabaceae19.9
Salix24.8
SpainHeterofloral12.5–20.8[84,87]
Cistus12.6–22.5
Table 3. Antiviral activities of propolis and its components.
Table 3. Antiviral activities of propolis and its components.
Propolis Type and Its ComponentsOrganismTested ModelOutcome of the StudyReferences
Mexican propolisCanine distemper virusIn vitro African green monkey kidney cellsPropolis application decreased viral expression and correlated with increased cell viability.[110]
Propolis extractsHSV-1In vitro RC-37 cellsIC50 values of aqueous and ethanol extracts were determined at 0.0004% and 0.000035%, respectively.[111]
PropolisHIV-1In vitroPropolis abolished syncytium formation at 4.5 micrograms/mL and decreased p24 antigen production by as much as 90–100%.[112]
Propolis extractsHSV-1 and HSV-2In vitroStandardized preparations of propolis exhibited antiviral bioactivity.[26]
Brazilian propolis (kaempferol, KF and p-coumaric acid, and p-CA)Human rhinoviruses (HRVs)In vitro HeLa cellsThey inhibited HRV-3 infection when added during the early stages following virus inoculation.[113]
PropolisHSV-1In vitro Vero cells in vivo newborn ratsThe addition of 10% propolis extract led to 80–85% protection.[114]
Propolis extract GH-2002Varicella zoster virusIn vitro LEP cellsIC50 value was determined to be 64 μg/mL.[115]
Propolis extract ACF®HSV-1 and HSV-2In vitro MDBK cellsShowed pronounced virucidal effect and interfered with virus adsorption.[116]
Table 4. Chemical components of bee venom.
Table 4. Chemical components of bee venom.
Bee Venom ComponentsDry Weight%
PeptidesMelittin40–50
Apamine, MCD2–3
Secapine0.5–2
Minimine2
Pamine1–3
Adolapine0.5–1
Protease inhibitor0.1–0.8
Procamine (A, B), tertiapine, cardiopep, and melittin-F1–2
ProteinsPhospholipase A210–12
Hyaluronidase1–2
Phosphatase and phospholipase B1
α-Glucosidase0–6
SugarsGlucose and fructose2–4
MineralsCa, Mg, and P3–4
AminesAminobutyric acid, α-amino acids1
Noradrenaline0.1–0.5
Histamine0.5–2
Dopamine0.2–1
Volatile compounds
(pheromones)
Complex ethers4–8
Table 5. Antiviral activities of bee venom and its components.
Table 5. Antiviral activities of bee venom and its components.
Bee Venom or ExtractOrganismTested ModelOutcome of the StudyReferences
Bee venomVesicular stomatitis virus (VSV), coxsackievirus (H3), herpes simplex virus (HSV), enterovirus-71 (EV-71), influenza A virus (PR8), and respiratory syncytial virus (RSV)In vitro HEK293T, MDCK, HEp2, Vero cells, and HeLaIt is concluded that bee venom would be a promising antiviral agent, especially in the establishment of a broad-spectrum antiviral agent.[136]
Bee venomPorcine reproductive and
respiratory syndrome virus (PRRSV)
In vivo pigsEspecially nasal or rectal application of bee venom may be used in the prevention of this infection in pigs.[137]
Bee venom (phospholipase A2)Dengue virus (DENV), hepatitis C virus (HCV), and Japanese encephalitis virus (JEV)In vitro Huh7it-1 cells, MDCK, HEK293T, and Vero cells and in vivo embryonated eggsPhospholipase A2 and its derivatives could be potent candidates for the development of broad-spectrum antiviral drugs that exert their effects by targeting viral envelope lipid bilayers derived from the ER membrane.[138]
Bee venomLumpy skin disease virus (LSDV)In vitro Maiden-Darby bovine kidney cells (MDBK), Hep-2, and MCF7 and in vivo embryonated chicken eggsBee venom could serve as a good treatment for LSDV after determination of suitable therapeutic doses.[139]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Asma, S.T.; Bobiş, O.; Bonta, V.; Acaroz, U.; Shah, S.R.A.; Istanbullugil, F.R.; Arslan-Acaroz, D. General Nutritional Profile of Bee Products and Their Potential Antiviral Properties against Mammalian Viruses. Nutrients 2022, 14, 3579. https://doi.org/10.3390/nu14173579

AMA Style

Asma ST, Bobiş O, Bonta V, Acaroz U, Shah SRA, Istanbullugil FR, Arslan-Acaroz D. General Nutritional Profile of Bee Products and Their Potential Antiviral Properties against Mammalian Viruses. Nutrients. 2022; 14(17):3579. https://doi.org/10.3390/nu14173579

Chicago/Turabian Style

Asma, Syeda Tasmia, Otilia Bobiş, Victoriţa Bonta, Ulas Acaroz, Syed Rizwan Ali Shah, Fatih Ramazan Istanbullugil, and Damla Arslan-Acaroz. 2022. "General Nutritional Profile of Bee Products and Their Potential Antiviral Properties against Mammalian Viruses" Nutrients 14, no. 17: 3579. https://doi.org/10.3390/nu14173579

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop